One-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2–4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis.

Autor: McGarvey, Lorcan1 (AUTHOR) l.mcgarvey@qub.ac.uk, Niewoehner, Dennis2 (AUTHOR), Magder, Sheldon3 (AUTHOR), Sachs, Paul4 (AUTHOR), Tetzlaff, Kay5,6 (AUTHOR), Hamilton, Alan7 (AUTHOR), Korducki, Lawrence8 (AUTHOR), Bothner, Ulrich5 (AUTHOR), Vogelmeier, Claus9 (AUTHOR), Koch, Andrea10 (AUTHOR), Ferguson, Gary T.11 (AUTHOR)
Zdroj: COPD: Journal of Chronic Obstructive Pulmonary Disease. Oct2015, Vol. 12 Issue 5, p484-493. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje